Immuno-oncology and molecular oncology are two of Sanofi's most promising bets to tackle some of the most difficult-to-treat cancers. While immuno-oncology research is focused on finding...
Hemogenyx Pharmaceuticals Ltd. will start trading on the London Stock Exchange under the ticker symbol HEMO on Thursday, October 5, 2017.